Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole

Triple therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) for the elimination of lymphatic filariasis (LF) represents a compelling example of accelerating the timeline from development to introduction and impact. Previous articles outlined how the clinical development process was abl...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Jonathan D., Jacobson, Julie, Krentel, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154640/
https://www.ncbi.nlm.nih.gov/pubmed/35292578
http://dx.doi.org/10.4269/ajtmh.21-0972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154640/
https://www.ncbi.nlm.nih.gov/pubmed/35292578
http://dx.doi.org/10.4269/ajtmh.21-0972

Ejemplares similares